Benitec Biopharma Inc. (BNTC): Price and Financial Metrics
BNTC Price/Volume Stats
| Current price | $10.30 | 52-week high | $13.29 |
| Prev. close | $11.06 | 52-week low | $2.69 |
| Day low | $10.30 | Volume | 30,600 |
| Day high | $11.38 | Avg. volume | 46,918 |
| 50-day MA | $11.04 | Dividend yield | N/A |
| 200-day MA | $9.20 | Market Cap | 239.12M |
BNTC Stock Price Chart Interactive Chart >
Benitec Biopharma Inc. (BNTC) Company Bio
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. The company was founded in 1995 and is headquartered in Hayward, California.
BNTC Price Returns
| 1-mo | -9.73% |
| 3-mo | -4.01% |
| 6-mo | 12.81% |
| 1-year | 261.39% |
| 3-year | -75.67% |
| 5-year | -91.31% |
| YTD | -18.45% |
| 2024 | 291.02% |
| 2023 | 11.76% |
| 2022 | -93.51% |
| 2021 | -12.67% |
| 2020 | -60.78% |
Continue Researching BNTC
Want to see what other sources are saying about Benitec Biopharma LTD's financials and stock price? Try the links below:Benitec Biopharma LTD (BNTC) Stock Price | Nasdaq
Benitec Biopharma LTD (BNTC) Stock Quote, History and News - Yahoo Finance
Benitec Biopharma LTD (BNTC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...